EP12.01-22 Evaluation of the LITE-Risk Prognostic Model in Consolidation Durvalumab and Osimertinib-Treated NSCLC
| Autor: | Gibson, A., Dean, M., Heng, D.Y., Meyers, D.E., Ruan, Y., Sangha, R., Stukalin, I., Cheung, W.Y., Navani, V. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2023 18(11) Supplement:S649-S649 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|